Evidence map›Paper›PMID 37180522›Full record

ReviewJournal of current ophthalmology

Management of Malignant Glaucoma.

Reza Sadeghi, Ali Momeni, Ghasem Fakhraie, Yadollah Eslami, Reza Zarei, Zakieh Vahedian, Mona Safizadeh, Seyed Mehdi Tabatabaei

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of current ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Late-onset malignant glaucoma associated with Soemmering's ring: A case report.The Journal of international medical research · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Reza SadeghiGlaucoma Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ali MomeniGlaucoma Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ghasem FakhraieGlaucoma Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Yadollah EslamiGlaucoma Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Reza ZareiGlaucoma Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Zakieh VahedianGlaucoma Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mona SafizadehGlaucoma Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Seyed Mehdi TabatabaeiGlaucoma Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRFarabi Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To compare the outcomes of various invasive and noninvasive approaches to the treatment of malignant glaucoma. Methods: Glaucoma-related keywords were looked up in PubMed and Google Scholar, and related articles up to 2022 were used to put together this review article. Results: Numerous surgical methods and techniques have been introduced in the past few years. This review outlined current knowledge regarding the nonsurgical and surgical management of malignant glaucoma. In this regard, we first briefly outlined the clinical presentation, pathophysiology, and diagnosis of this disorder. Then, the current evidence on the management of malignant glaucoma was reviewed. Finally, we discuss the need for treatment of the other eye and the factors that might affect the outcome of surgical intervention. Conclusions: Fluid misdirection syndrome, or malignant glaucoma, is a severe disorder that can occur spontaneously due to surgical intervention. The pathophysiology of malignant glaucoma is complicated, and numerous theories exist about the underlying mechanisms that may contribute to the disease. Malignant glaucoma can be treated conservatively using medications, laser therapy, or surgery. Laser treatments and medical treatments have been adequate for the treatment of glaucoma, but the effects have generally been short-lived, and surgical treatment has proved to be the most effective. There have been a variety of surgical methods and techniques introduced. Still, none have been studied in a large proportion of patients as a control case to compare effectiveness, outcomes, and recurrence. Pars plana vitrectomy with irido-zonulo-capsulectomy still seems to have the best results.

Indexed as

Fluid misdirection syndromeLaser therapyMalignant glaucomaMedical interventionSurgical intervention

Identifiers

PMID37180522
PMCPMC10170992
OpenAlexW4376642116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.